Why is Remedium Life falling/rising?

As of 29-Aug, Remedium Lifecare Ltd's stock price is currently at 1.31, reflecting an increase of 0.06 or 4.8%. The stock has shown a trend reversal by gaining after three consecutive days of decline and has outperformed its sector by 4.17% today. However, despite this short-term gain, the stock has a troubling performance history, with a year-to-date decline of 63.35% and a staggering 81.51% drop over the past year. The company has reported negative results for the last four consecutive quarters, with significant losses and a negative return on capital employed (ROCE). Additionally, the high Debt to EBITDA ratio indicates a low ability to service debt, further complicating its financial outlook.
In the broader market context, while the Sensex has experienced a slight decline of 1.84% over the past week, Remedium Lifecare's stock has decreased by 1.50% during the same period, indicating that it has underperformed the benchmark in the short term. The stock's liquidity remains adequate for trading, but the falling investor participation, as evidenced by a 6.97% drop in delivery volume, raises concerns about sustained interest in the stock. Overall, despite today's positive movement, the underlying financial challenges and poor long-term growth prospects suggest that the stock's recent rise may not be indicative of a sustainable recovery.